BR112016003082A8 - uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida - Google Patents

uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida Download PDF

Info

Publication number
BR112016003082A8
BR112016003082A8 BR112016003082A BR112016003082A BR112016003082A8 BR 112016003082 A8 BR112016003082 A8 BR 112016003082A8 BR 112016003082 A BR112016003082 A BR 112016003082A BR 112016003082 A BR112016003082 A BR 112016003082A BR 112016003082 A8 BR112016003082 A8 BR 112016003082A8
Authority
BR
Brazil
Prior art keywords
wound
tropoelastine
reepithelization
heal
medicine
Prior art date
Application number
BR112016003082A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112016003082A2 (pt
Inventor
Anthony Steven Weiss
Original Assignee
Elastagen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by Elastagen Pty Ltd filed Critical Elastagen Pty Ltd
Publication of BR112016003082A2 publication Critical patent/BR112016003082A2/pt
Publication of BR112016003082A8 publication Critical patent/BR112016003082A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
BR112016003082A 2013-08-13 2014-08-13 uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida BR112016003082A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Publications (2)

Publication Number Publication Date
BR112016003082A2 BR112016003082A2 (pt) 2017-08-01
BR112016003082A8 true BR112016003082A8 (pt) 2020-01-28

Family

ID=52467858

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016003082A BR112016003082A8 (pt) 2013-08-13 2014-08-13 uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida

Country Status (12)

Country Link
US (4) US20160194379A1 (https=)
EP (2) EP4316537A3 (https=)
JP (3) JP6382311B2 (https=)
KR (3) KR20160041949A (https=)
CN (2) CN110464837A (https=)
AU (3) AU2014306362B2 (https=)
BR (1) BR112016003082A8 (https=)
CA (1) CA2920312C (https=)
ES (1) ES2965893T3 (https=)
MX (2) MX377200B (https=)
RU (1) RU2677637C2 (https=)
WO (1) WO2015021508A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
BR112015013627A2 (pt) 2012-12-10 2017-07-11 Elastagen Pty Ltd elástico escalável tridimensional, fabricação e construção
JP6382311B2 (ja) * 2013-08-13 2018-08-29 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ 損傷組織の再生
AU2016314775A1 (en) * 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
WO2018081866A1 (en) * 2016-11-04 2018-05-11 Elastagen Pty Ltd Biosynthetic devices
EP3962517A1 (en) * 2019-05-03 2022-03-09 Allergan Pharmaceuticals International Limited Scar prevention and/or treatment
WO2022076117A1 (en) * 2020-09-08 2022-04-14 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
AU645794B2 (en) 1990-03-30 1994-01-27 Shiseido Company Ltd. Process for purifying polypeptide
SG41929A1 (en) 1992-09-25 1997-08-15 Commw Scient Ind Res Org Target binding polypeptide
WO1994014958A1 (en) * 1992-12-22 1994-07-07 The University Of Sydney Synthetic polynucleotides
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
CA2262446A1 (en) 1996-08-07 1998-02-12 Protein Specialties, Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
WO1998034563A1 (en) 1997-02-07 1998-08-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2383539C (en) * 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
AU1375301A (en) 1999-11-15 2001-05-30 Bio Syntech Canada Inc Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
US7125960B2 (en) 2001-05-30 2006-10-24 Chisso Corporation Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US7666829B2 (en) 2004-02-20 2010-02-23 Human Matrix Sciences, Llc Compositions for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
WO2006101441A2 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
EP1945144A4 (en) 2005-10-19 2012-12-05 Kenton W Gregory PROCESS FOR THE USE AND PRODUCTION OF TROPOELASTIN AND BIOMATERIALS BASED ON TROPOELASTIN
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
AU2007285483B2 (en) * 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
EP2097115B1 (en) * 2006-11-13 2017-01-25 Elastagen Pty Ltd Use of tropoelastin for repair or restoration of tissue
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
WO2009099570A2 (en) 2008-02-01 2009-08-13 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
ES2871977T3 (es) * 2009-03-10 2021-11-02 Allergan Pharmaceuticals Int Ltd Biomateriales inyectables
EP3078388B1 (en) 2010-03-22 2019-02-20 Allergan, Inc. Cross-linked hydrogels for soft tissue augmentation
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
JP2013544593A (ja) * 2010-11-23 2013-12-19 エラスタジェン ピーティーワイ リミテッド 多糖によって架橋されているタンパク質の調製および／または調合物
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
EP3505180B1 (en) 2011-09-30 2022-08-03 Allergan Pharmaceuticals International Limited In vivo synthesis of elastic fiber
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
BR112015013627A2 (pt) 2012-12-10 2017-07-11 Elastagen Pty Ltd elástico escalável tridimensional, fabricação e construção
JP6382311B2 (ja) * 2013-08-13 2018-08-29 エラスタジェン・プロプライエタリー・リミテッドＥｌａｓｔａｇｅｎ Ｐｔｙ Ｌｔｄ 損傷組織の再生
RU2733495C2 (ru) 2013-09-24 2020-10-02 Аллерган Фармасьютикалз Интернэшнл Лимитед Способ экстракции белка

Also Published As

Publication number Publication date
US20250171522A1 (en) 2025-05-29
JP6382311B2 (ja) 2018-08-29
JP6639587B2 (ja) 2020-02-05
AU2019204972A1 (en) 2019-08-01
RU2016104618A3 (https=) 2018-06-18
AU2021245202B2 (en) 2025-01-23
CA2920312A1 (en) 2015-02-19
EP4316537A2 (en) 2024-02-07
US20220098281A1 (en) 2022-03-31
JP2020049282A (ja) 2020-04-02
AU2014306362B2 (en) 2019-04-18
US20190062405A1 (en) 2019-02-28
ES2965893T3 (es) 2024-04-17
RU2677637C2 (ru) 2019-01-18
BR112016003082A2 (pt) 2017-08-01
AU2014306362A1 (en) 2016-02-18
AU2019204972B2 (en) 2021-07-08
KR102488446B1 (ko) 2023-01-13
WO2015021508A1 (en) 2015-02-19
AU2021245202A1 (en) 2021-11-04
JP6891257B2 (ja) 2021-06-18
KR20230004965A (ko) 2023-01-06
CA2920312C (en) 2022-07-19
MX2016001436A (es) 2016-07-05
CN105530951A (zh) 2016-04-27
US11084867B2 (en) 2021-08-10
JP2016527979A (ja) 2016-09-15
JP2018164789A (ja) 2018-10-25
EP3033099A4 (en) 2017-04-12
MX2020011880A (es) 2021-01-20
EP4316537A3 (en) 2024-04-10
EP3033099B1 (en) 2023-11-01
KR20210154881A (ko) 2021-12-21
EP3033099A1 (en) 2016-06-22
CN110464837A (zh) 2019-11-19
CN105530951B (zh) 2019-10-22
RU2016104618A (ru) 2017-09-14
KR20160041949A (ko) 2016-04-18
US20160194379A1 (en) 2016-07-07
MX377200B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
BR112016003082A8 (pt) uso da tropoelastina na produção de um medicamento para cicatrização de uma ferida ou para melhora da reepitelização de uma ferida
CY1122648T1 (el) Διαδικασια για την παρασκευη συνθεσεων που περιεχουν υαλουρονικο οξυ και υδροχλωρικη μεπιβακαϊνη
MX391624B (es) Métodos de uso de indazol-3-carboxamidas y su uso como inhibidores de la ruta de señalización de wnt/b-catenina.
CY1121736T1 (el) Άλατα aramchol
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
AR099354A1 (es) Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
BR112015020804A2 (pt) dispositivo fototerapeutico, método e uso
MX2016009852A (es) Sistemas para el cuidado de la piel despues del procedimiento, composiciones y metodos de uso de los mismos.
BR112015023987A2 (pt) creme dental de duas fases
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
DOP2013000218A (es) Anticuerpos monoclonales frente al inhibidor de la ruta del factor tisular (tfpi)
BR112015026388A2 (pt) métodos e composições para cicatrização de feridas
BR112014011481A2 (pt) hidrolisado de colágeno e seu uso
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
BR112015027477A2 (pt) método para tratamento de um transtorno de deglutição
BR112016028895A2 (pt) composições biofotônicas termofixas e usos destas
MX358845B (es) Combinacion sinergica de alanina-glutamina, acido hialuronico y un extracto de avena y su uso en una composicion destinada para la curacion de heridas y reparacion de lesiones de la piel.
BR112014000795A2 (pt) uso cosmético e/ou dermatológico de compostos oligossacarídeos na prevenção e no tratamento de estrias
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
BR112015028367A2 (pt) modulação de atividade de fator de crescimento epidérmico de ligação de heparina para cura de membrana de tímpano
BR112015027992A2 (pt) uso de ácido petroselínico para combater desordens estéticas da figura do corpo
AR097678A1 (es) Composición para el cuidado oral que comprende un gel diluido de alginato de sodio y calcio
AR093717A1 (es) Composiciones y metodos para el tratamiento de la caries dental
BR112015017432A2 (pt) métodos para o tratamento de indicações cardiovasculares

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B25A Requested transfer of rights approved

Owner name: ALLERGAN AUSTRALIA PTY LTD (AU)

B25A Requested transfer of rights approved

Owner name: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (IE)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]